Mo Y, Tan W, Cooper B
JAC Antimicrob Resist. 2025; 7(1):dlae215.
PMID: 39881797
PMC: 11775593.
DOI: 10.1093/jacamr/dlae215.
Chang C, Chang H, Lu M, Wegner A, Wu R, Yin T
Asian Spine J. 2025; 19(1):38-45.
PMID: 39829183
PMC: 11895135.
DOI: 10.31616/asj.2024.0388.
Almajid A, Almuyidi S, Alahmadi S, Bohaligah S, Alfaqih L, Alotaibi A
Cureus. 2024; 16(3):e57238.
PMID: 38686221
PMC: 11056812.
DOI: 10.7759/cureus.57238.
Kourbeti I, Kamiliou A, Samarkos M
Antibiotics (Basel). 2024; 13(4).
PMID: 38667005
PMC: 11047567.
DOI: 10.3390/antibiotics13040329.
Nielsen N, Dean 3rd J, Shald E, Morris A, Povoa P, Schouten J
Antibiotics (Basel). 2024; 13(3).
PMID: 38534707
PMC: 10967289.
DOI: 10.3390/antibiotics13030272.
Short-course antibiotic therapy: The next frontier in antimicrobial stewardship.
Sheppard D
Can Commun Dis Rep. 2024; 48(11-12):496-501.
PMID: 38173469
PMC: 10763651.
DOI: 10.14745/ccdr.v48i1112a01.
Skewed perception of personal behaviour as a contributor to antibiotic resistance and underestimation of the risks.
Smith E, Buchan S
PLoS One. 2023; 18(11):e0293186.
PMID: 37917754
PMC: 10621963.
DOI: 10.1371/journal.pone.0293186.
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
Doernberg S, Arias C, Altman D, Babiker A, Boucher H, Creech C
Clin Infect Dis. 2023; 77(Suppl 4):S295-S304.
PMID: 37843115
PMC: 10578051.
DOI: 10.1093/cid/ciad565.
Short-term antibiotic therapy for the most common bacterial respiratory infections in infants and children.
Principi N, Autore G, Argentiero A, Esposito S
Front Pharmacol. 2023; 14:1174146.
PMID: 37346296
PMC: 10279853.
DOI: 10.3389/fphar.2023.1174146.
Short course antibiotic treatment of Gram-negative bacteraemia (GNB5): a study protocol for a randomised controlled trial.
Tingsgard S, Bastrup Israelsen S, Thorlacius-Ussing L, Kirk K, Lindegaard B, Johansen I
BMJ Open. 2023; 13(5):e068606.
PMID: 37156588
PMC: 10173995.
DOI: 10.1136/bmjopen-2022-068606.
Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV.
Davar K, Clark D, Centor R, Dominguez F, Ghanem B, Lee R
Open Forum Infect Dis. 2023; 10(1):ofac706.
PMID: 36694838
PMC: 9853939.
DOI: 10.1093/ofid/ofac706.
Duration of antibiotic therapy for common infections.
Grant J, Le Saux N
J Assoc Med Microbiol Infect Dis Can. 2022; 6(3):181-197.
PMID: 36337760
PMC: 9615468.
DOI: 10.3138/jammi-2021-04-29.
Antimicrobial ethicists: Making ethics explicit in antimicrobial stewardship.
Yen C, Cutrell J
Antimicrob Steward Healthc Epidemiol. 2022; 1(1):e17.
PMID: 36168479
PMC: 9495412.
DOI: 10.1017/ash.2021.181.
Layered and integrated medical countermeasures against infections in C57BL/6 mice.
Klimko C, Shoe J, Rill N, Hunter M, Dankmeyer J, Talyansky Y
Front Microbiol. 2022; 13:965572.
PMID: 36060756
PMC: 9432870.
DOI: 10.3389/fmicb.2022.965572.
Detecting inappropriate total duration of antimicrobial therapy using semi-automated surveillance.
van den Broek A, de la Court J, Groot T, Van Hest R, Visser C, Sigaloff K
Antimicrob Resist Infect Control. 2022; 11(1):110.
PMID: 36038925
PMC: 9426230.
DOI: 10.1186/s13756-022-01147-2.
Two-day seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial.
Messous S, Trabelsi I, Ali K, Abdelghani A, Ben Daya Y, Razgallah R
Ther Adv Respir Dis. 2022; 16:17534666221099729.
PMID: 35657073
PMC: 9168850.
DOI: 10.1177/17534666221099729.
Mutational Switch-Backs Can Accelerate Evolution of to a Combination of Ciprofloxacin and Doxycycline.
Mehta H, Ibarra D, Marx C, Miller C, Shamoo Y
Front Microbiol. 2022; 13:904822.
PMID: 35615518
PMC: 9125183.
DOI: 10.3389/fmicb.2022.904822.
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection.
Howard-Anderson J, Dai W, Yahav D, Hamasaki T, Turjeman A, Koppel F
Open Forum Infect Dis. 2022; 9(6):ofac140.
PMID: 35615299
PMC: 9125302.
DOI: 10.1093/ofid/ofac140.
Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia.
Pettigrew M, Kwon J, Gent J, Kong Y, Wade M, Williams D
mBio. 2022; 13(2):e0019522.
PMID: 35323040
PMC: 9040816.
DOI: 10.1128/mbio.00195-22.
Duration of Antibiotic Therapy for General Medicine and General Surgery Patients Throughout Transitions of Care: An Antibiotic Stewardship Opportunity for Noninfectious Disease Pharmacists.
Brower K, Hecke A, Mangino J, Gerlach A, Goff D
Hosp Pharm. 2021; 56(5):532-536.
PMID: 34720157
PMC: 8554605.
DOI: 10.1177/0018578720928265.